Clinical Trials Browser

Phase 2 × futuximab × Head & Neck × Clear all

NCT01417936 2018-10-15

Sym004 in SCCHN Patients Failing Anti-EGFR Based Therapy

Phase 2 Completed

26 enrolled 20 charts

Squamous Cell Carcinoma of Head and Neck